Cargando…
Erratum: Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
Autores principales: | Shin, Gi Won, Park, Young Mi, Kim, Tae Hyun, Lee, Anbok, Park, Ha Young, Yoon, Hye Kyoung, Heo, Young Jin, Baek, Jin Wook, Lee, Yoo Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431900/ https://www.ncbi.nlm.nih.gov/pubmed/36238627 http://dx.doi.org/10.3348/jksr.2020.81.3.753 |
Ejemplares similares
-
Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
Publicado: (2020) -
Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Shin, Gi Won, et al.
Publicado: (2016) -
Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
por: Choi, Min Chul, et al.
Publicado: (2018) -
Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
por: Lee, Sang Jin, et al.
Publicado: (2017) -
Erratum to: Progression of GNE Myopathy Based on the Patient-Reported Outcome
por: Park, Young-Eun, et al.
Publicado: (2020)